Search
for
Sort by
Research 121–150 of 667
- Rely on clinical experience to help guide treatment selection for primary cicatricial (scarring) alopecias
- Graft-versus-host disease with acute hair loss: A distinctive manifestation of chronic graft-versus-host disease
- Naked Hair Shafts as a Marker of Cicatricial Alopecia
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Differential diagnosis of posterior scalp hair loss
- Oxidative stress in ageing of hair
- Aging of hair
- Evaluation of hair loss
- Secondary cicatricial and other permanent alopecias
- The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics
- Dermatopathology of Common Hair Problems
- Cicatricial Alopecia
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Dermatoscopic features of central centrifugal cicatricial alopecia
- Traction alopecia: the root of the problem
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- Cicatricial (Scarring) Alopecias
- Scalp Itch: A Systematic Review
- Hair and nail involvement in lupus erythematosus
- A study of serial vertical sectioning of scalp biopsies to increase the histological diagnostic yield in alopecias
- Problems in pattern alopecia
- Atlas of Geriatric Dermatology
- Frontal fibrosing alopecia and lichen planopilaris: epidemiology, treatment, and remission rate (2014-2024)
- Non-Neoplastic Disorders of Hair
- Involvement of scalp and nails in lupus erythematosus
- Syphilitic Alopecia: A Report of 5 Cases and a Review of the Literature
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- Lupus erythematosus: systemic and cutaneous manifestations
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors